Andrea Fritzer
YOU?
Author Swipe
View article: From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine
From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine Open
Background Over the past 20 years, over 5 million cases of chikungunya, a mosquito-transmitted viral disease, have been reported in over 110 countries. Until recently, preventative strategies for chikungunya were largely ineffective, relyi…
View article: Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera
Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera Open
Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus responsible for numerous outbreaks. Chikungunya can cause debilitating acute and chronic disease. Thus, the development of a safe and effective CHIKV vaccine is an urgent …